Search Result
Results for "
targeting+drug+delivery
" in MedChemExpress (MCE) Product Catalog:
132
Biochemical Assay Reagents
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-144009
-
|
|
Liposome
|
Cancer
|
|
DSPE-PEG-Folate, MW 3350 is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
-
- HY-160523
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DBCO Ir catalyst is an iridium catalyst labeled with DBCO. DBCO Ir catalyst can be used for in situ labeling and imaging of biomolecules (e.g., proteins, nucleic acids) in living organisms or for constructing targeted drug delivery systems .
|
-
-
- HY-170706
-
|
|
Liposome
|
Cancer
|
|
DSPE-PEG (2000)-COOH is a pegylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530) . DSPE-PEG2000-COOH can form micelles for targeted drug delivery .
|
-
-
- HY-78736
-
|
|
ADC Linker
|
Cancer
|
|
Val-Cit-PAB-OSBT is a degradable ADC linker composed of the peptide Val-Cit-PAB and the OSBT group, which ensures stable performance during targeted drug delivery .
|
-
-
- HY-W440917
-
|
|
Liposome
|
Others
|
|
DSPE-PEG5000-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
-
- HY-147287
-
|
|
PSMA
Drug Intermediate
|
Cancer
|
|
Glu-urea-Glu-NHS ester is an activated N-hydroxysuccinamide (NHS) ester of Glu-urea-Glu. Glu-urea-Glu-NHS ester can be used for synthesis of small-molecule prostate-specific membrane antigen (PSMA) inhibitors, imaging agents (such as PSMAi-PEG conjugates), and targeted drug delivery vehicles .
|
-
-
- HY-139819
-
|
|
Biochemical Assay Reagents
|
Others
|
|
MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer, which can be used to preparenanoparticles for targeted drug delivery .
|
-
-
- HY-W441015A
-
|
|
Liposome
|
Others
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
-
- HY-W440916
-
|
|
Liposome
|
Others
|
|
DSPE-PEG3400-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
-
- HY-W440890
-
|
|
Liposome
|
Cancer
|
|
DSPE-PEG-Folate, MW 5000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 5000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 5000 form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
-
- HY-139818
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mal-PEG-PLA (PEG MW 3000 & PLA MW 70,000) is a block copolymer, which can be used to preparenanoparticles and micelles for targeted drug delivery .
|
-
-
- HY-P2548
-
|
|
EGFR
|
Others
|
|
pp60 (v-SRC) Autophosphorylation Site, Phosphorylated is the phosphorylated peptide of an EGFR substrate. pp60 (v-SRC) Autophosphorylation Site, Phosphorylated can be used for the screening of EGFR Kinase inhibitors via phosphorylated-substrate quantification .
|
-
-
- HY-166975
-
|
pSar 100
|
Biochemical Assay Reagents
|
Others
|
|
Polysarcosine 100 (pSar 100) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 100 can be used in drug delivery research .
|
-
-
- HY-W1123932A
-
|
mPEG2000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
mPEG2000-FA (mPEG2000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
-
- HY-W440899
-
|
|
Liposome
|
Others
|
|
DSPE-PEG1000-SPDP is a thiol reactive PEG lipid. The polymer is amphiphilic and spontaneously forms lipid bilayer in water. It can be used to encapsulate nutrients or therapeutics for targeted drug delivery, for example mRNA or DNA vaccine, liposomal doxorubicin for anti tumor.
|
-
-
- HY-101993
-
|
|
Amino Acid Derivatives
|
Others
|
|
Nap-FF is a cell-penetrating dipeptide that can be used in the preparation of hydrogel chemosensors and in the research of targeted drug delivery .
|
-
-
- HY-174972A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG-DPPE (MW 5000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-174947
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2-mal is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-W440892
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE-PEG3400-OH is an amphiphilic polydisperse PEG which can spontaneously self-assemble in aqueous solution. The polymer can be used to prepare liposoome for targeted drug delivery.
|
-
-
- HY-P10983
-
|
|
Biochemical Assay Reagents
|
Cancer
|
|
LS10 can specifically bind to NG2 protein and is a functional ligand for targeted drug delivery to glioma. NG2 proteins are widely overexpressed in the glioma cells and restricted in normal tissue .
|
-
-
- HY-166973
-
|
pSar 20
|
Biochemical Assay Reagents
|
Others
|
|
Polysarcosine 20 (pSar 20) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 20 can be used in drug delivery research .
|
-
-
- HY-166974
-
|
pSar 150
|
Biochemical Assay Reagents
|
Others
|
|
Polysarcosine 150 (pSar 150) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 150 can be used in drug delivery research .
|
-
-
- HY-W1123932
-
|
mPEG1000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-FA (mPEG1000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
-
- HY-W440888B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE-PEG3400-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
-
- HY-W440888A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE-PEG1000-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
-
- HY-W440921
-
|
|
Liposome
|
Others
|
|
DSPE-PEG5000-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
-
- HY-W440920
-
|
|
Liposome
|
Others
|
|
DSPE-PEG3400-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
-
- HY-W440888C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE-PEG5000-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
-
- HY-174966B
-
|
BOC-NH-PEG1000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG1000-FA (BOC-NH-PEG1000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
-
- HY-174966
-
|
BOC-NH-PEG400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG400-FA (BOC-NH-PEG400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
-
- HY-W440991
-
|
DOPE-PEG2000-NH2
|
Liposome
|
Cancer
|
|
DOPE-PEG-Amine (MW 2000) is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelle formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form a triazole ring.
|
-
-
- HY-W1130412
-
|
|
Liposome
|
Others
|
|
DLPE-mPEG2000 is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-174972
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG-DPPE (MW 1000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-185470
-
|
|
Integrin
|
Others
|
|
L123Z358 is a ligand of αvβ6 integrin. L123Z358 can be conjugated with siRNA to achieve targeted drug delivery to muscle tissue .
|
-
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DSG is a PEGylated phospholipid containing DSG. mPEG1000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DSG is a PEGylated phospholipid containing DSG. mPEG500-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052192B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DMPE is a PEGylated phospholipid containing DMPE. mPEG20000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DSG is a PEGylated phospholipid containing DSG. mPEG550-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052192C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DMPE is a PEGylated phospholipid containing DMPE. mPEG30000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1048624C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DSG is a PEGylated phospholipid containing DSG. mPEG20000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W591381H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DSG is a PEGylated phospholipid containing DSG. mPEG30000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DSG is a PEGylated phospholipid containing DSG. mPEG10000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG5000-DSG is a PEGylated phospholipid containing DSG. mPEG5000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1123932B
-
|
mPEG5000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
mPEG5000-FA (mPEG5000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DSG is a PEGylated phospholipid containing DSG. mPEG750-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DMPE is a PEGylated phospholipid containing DMPE. mPEG10000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DSG is a PEGylated phospholipid containing DSG. mPEG350-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-183170C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG5000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG1000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG3400-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG2000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG10000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-174966D
-
|
BOC-NH-PEG3400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG3400-FA (BOC-NH-PEG3400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-183164B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG3400-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-174966C
-
|
BOC-NH-PEG2000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG2000-FA (BOC-NH-PEG2000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174966E
-
|
BOC-NH-PEG5000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG5000-FA (BOC-NH-PEG5000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-183164A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG2000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG10000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG1000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-174966H
-
|
BOC-NH-PEG10000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG10000-FA (BOC-NH-PEG10000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174966A
-
|
BOC-NH-PEG600-Folate
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG600-FA (BOC-NH-PEG600-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-183164C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG5000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183160B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG3400-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183160A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG2000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183160D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG10000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183160
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG1000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183160C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG5000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG10000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG3400-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG1000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG2000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-W440833
-
|
|
Liposome
|
Others
|
|
DSPE-PEG3400-azide is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelles formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form triazole bond.
|
-
- HY-183163C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG5000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-W1123921E
-
|
4-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG5000-FA (4-Arm-PEG5000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921
-
|
4-Arm-PEG400-folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG400-FA (4-Arm-PEG400-folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945C
-
|
8-Arm-PEG2000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG2000-FA (8-Arm-PEG2000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921A
-
|
4-Arm-PEG600-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG600-FA (4-Arm-PEG600-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945E
-
|
8-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG5000-FA (8-Arm-PEG5000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945A
-
|
8-Arm-PEG600-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG600-FA (8-Arm-PEG600-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921C
-
|
4-Arm-PEG2000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG2000-FA (4-Arm-PEG2000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945H
-
|
8-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG10000-FA (8-Arm-PEG10000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945D
-
|
8-Arm-PEG3400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG3400-FA (8-Arm-PEG3400-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945
-
|
8-Arm-PEG400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG400-FA (8-Arm-PEG400-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921H
-
|
4-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG10000-FA (4-Arm-PEG10000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123945B
-
|
8-Arm-PEG1000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
8-Arm-PEG1000-FA (8-Arm-PEG1000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921B
-
|
4-Arm-PEG1000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG1000-FA (4-Arm-PEG1000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1123921D
-
|
4-Arm-PEG3400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
4-Arm-PEG3400-FA (4-Arm-PEG3400-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W440903
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSPE-PEG5000-IA is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
-
- HY-W591332
-
|
|
Liposome
|
Cancer
|
|
mPEG2000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the other end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications.
|
-
- HY-W440926
-
|
|
Liposome
|
Others
|
|
Stearic acid-PEG1000-NHS is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
-
- HY-159701A
-
|
|
Drug Intermediate
|
Others
|
|
DBCO-PEG2000-alendronic acid sodium is a PEG linker conjugated with alendronic acid (HY-B0631) and DBCO groups. Alendronic acid possesses bone-targeting properties, enabling strong chelation with calcium ions in bone and hydroxyapatite, and exhibits high specific adsorption on mineralized tissues such as bones and teeth. This compound can be applied to construct bone-targeted drug delivery systems and bone tissue imaging probes.
|
-
- HY-W591332A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the?other?end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-183162A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG2000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
-
- HY-183162D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG10000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
-
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183162
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG1000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
-
- HY-183162B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG3400-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
-
- HY-185404
-
|
|
Drug Intermediate
|
Others
|
|
DSPE-PEG8-OH is a monodisperse lipid-polyethylene glycol conjugate featuring a hydrophobic 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) anchor, an 8-unit discrete (PEG8) spacer, and a terminal hydroxyl (-OH) group. DSPE-PEG8-OH is primarily used in liposome formulation, nanoparticle surface modification, and targeted drug delivery systems.
|
-
- HY-174892
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG5-NHS ester is a heterobifunctional crosslinker as well as a polyethylene glycol-containing bioconjugation reagent. Biotin-PEG5-NHS ester is widely used in scientific research fields such as the construction of highly sensitive biosensors, the development of targeted drug delivery systems (e.g., liposome modification), immunofluorescence imaging, and protein affinity purification, and serves as an important tool for achieving precise labeling and functionalization of biomolecules .
|
-
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161
-
|
Glucose-PEG1000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183162C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG5000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
-
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-P10789
-
|
|
Microtubule/Tubulin
|
Cancer
|
|
The P160 peptide is a breast cancer-targeting peptide that binds to the keratin 1 (KRT1) receptor on breast cancer cells, with a Kd of approximately 1.1 μM, demonstrating significant potential for targeted drug delivery to breast cancer cells. The P160 peptide enhances the cellular uptake and anticancer activity of the pro-apoptotic antimicrobial peptide MccJ25 (microcin J25). The P160 peptide can be used in cancer research .
|
-
- HY-174960D
-
|
6-Arm-PEG3400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG3400-FA (6-Arm-PEG3400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-182095A
-
|
|
Liposome
|
Cardiovascular Disease
|
|
DSPE-PEG2000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG2000-CTP can be used for drug delivery .
|
-
- HY-174960E
-
|
6-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG5000-FA (6-Arm-PEG5000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174960B
-
|
6-Arm-PEG1000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG1000-FA (6-Arm-PEG1000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174960A
-
|
6-Arm-PEG600-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG600-FA (6-Arm-PEG600-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174960C
-
|
6-Arm-PEG2000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG2000-FA (6-Arm-PEG2000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-182095B
-
|
|
Liposome
|
Cardiovascular Disease
|
|
DSPE-PEG3400-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG3400-CTP can be used for drug delivery .
|
-
- HY-P1848
-
|
|
Interleukin Related
|
Cancer
|
|
Pep-1 (uncapped) is a specific ligand of IL-13Ra2. Pep-1 (uncapped) exerts cell penetrating activity through receptor-mediated endocytosis, can cross the blood-tumor barrier (BTB) and target glioma cells. Pep-1 (uncapped) can enhance the uptake of nanoparticles by tumor cells and enhance the cell penetration ability of nanoparticles, and can be used to develop targeted drug delivery systems for glioma .
|
-
- HY-182095C
-
|
|
Liposome
|
Cardiovascular Disease
|
|
DSPE-PEG5000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG5000-CTP can be used for drug delivery .
|
-
- HY-174960
-
|
6-Arm-PEG400-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG400-FA (6-Arm-PEG400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174960H
-
|
6-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
Others
|
|
6-Arm-PEG10000-FA (6-Arm-PEG10000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-182095
-
|
|
Liposome
|
Cardiovascular Disease
|
|
DSPE-PEG1000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG1000-CTP can be used for drug delivery .
|
-
- HY-W440888
-
|
DSPE-PEG2000(2000) Folate
|
Liposome
Folate Receptor (FR)
|
Cancer
|
|
DSPE-PEG2000-Folate (DSPE-PEG2000 Folate) is a folate-containing PEG derivative. DSPE-PEG2000-Folate possesses targeting activity and binds to folate receptors in cancer cells. DSPE-PEG2000-Folate can be post-inserted into preformed liposomal bilayers to prepare folate-targeted liposomal formulations. DSPE-PEG2000-Folate forms micelles/lipid bilayers and can be used in studies of targeted drug delivery systems [2].
|
-
- HY-P11015
-
|
|
Ephrin Receptor
|
Cancer
|
|
(123B9)2-Motif is a selective EphA2 receptor agonist (Kd=4.9 μM) that does not bind to EphA4. (123B9)2-Motif works by inducing EphA2 receptor phosphorylation and oligomerization, thereby promoting receptor activation and internalization. (123B9)2-Motif is primarily used in targeted drug delivery studies for cancers that overexpress EphA2, such as breast cancer, to reduce circulating tumor cells and inhibit metastasis .
|
-
- HY-172705
-
|
|
Liposome
nAChR
|
Neurological Disease
|
|
DSPE-PEG2000-RVG29 is a PEG conjugate composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB), crosses the BBB, and mediates receptor-dependent transcytosis. DSPE-PEG2000-RVG29 can be used for brain-targeted drug delivery, surface modification of nanocarriers, as well as gene and nucleic acid delivery. DSPE-PEG2000-RVG29 is applicable to research related to hypoxic-ischemic brain injury, Parkinson's disease, and other conditions .
|
-
- HY-N5139
-
|
Lecithins, egg yolk; Belovo PL 85
|
Cholinesterase (ChE)
Angiotensin-converting Enzyme (ACE)
Bacterial
|
Infection
Neurological Disease
Metabolic Disease
Inflammation/Immunology
|
|
Lecithins, egg (Lecithins, egg yolk; Belovo PL 85) is an orally active natural phospholipid mixture extracted from egg yolks . Lecithins, egg inhibits the activities of acetylcholinesterase (AChE) and angiotensin-converting enzyme (ACE). Lecithins, egg exhibits antibacterial, antioxidant and anti-inflammatory activities, and helps delay cellular senescence. Lecithins, egg enhances nerve conduction, improves memory and cognitive function, and exerts positive effects on delaying neurodegenerative diseases. Lecithins, egg promotes lipid absorption and alleviates diarrhea. Lecithins, egg acts as a high-efficiency drug carrier for the preparation of targeted drug delivery systems such as liposomes .
|
-
- HY-172705A
-
|
|
Liposome
nAChR
|
Infection
|
|
DSPE-PEG3400-RVG29 is a PEG conjugate composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB), crosses the BBB, and mediates receptor-dependent transcytosis. DSPE-PEG3400-RVG29 can be used for brain-targeted drug delivery, surface modification of nanocarriers, as well as gene and nucleic acid delivery. DSPE-PEG3400-RVG29 is applicable to research related to hypoxic-ischemic brain injury, Parkinson's disease, and other conditions
|
-
- HY-P5423
-
|
|
Exosomes
Liposome
|
Cancer
|
|
GALA is a pH-responsive amphipathic peptide consisting of 30 amino acids, which acts as a lung endothelium-targeting ligand. GALA undergoes a conformational transition from random coil to α-helix in an acidic environment at pH 5.0, thereby inducing endosomal membrane destabilization and fusion. GALA-modified liposomes traverse lung endothelial cells via clathrin-dependent endocytosis and transcytosis, and specifically accumulate in the lungs after intravenous injection. GALA significantly promotes the cytosolic release of cargos carried by exosomes, plasmids and liposomes, effectively enhances gene transfection efficiency, and drives gene knockdown of functional macromolecules (such as siRNA) in alveolar epithelial cells (with no significant cytotoxicity at effective concentrations). GALA serves as a critical tool for studies on lung cancer metastasis (e.g., melanoma lung metastasis) and lung-targeted drug delivery systems .
|
-
- HY-177204
-
|
|
Ferroptosis
Apoptosis
Glutathione Peroxidase
|
Cardiovascular Disease
|
|
DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW is a polypeptide targeting tenascin-X (Tenascin-X) that can be conjugated with liposomes and exosomes. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW specifically binds to Tenascin-X on the surface of cardiomyocytes, mediates receptor-dependent uptake of nanocarriers, enhances targeted drug delivery of cargo to cardiomyocytes, and increases drug accumulation in cardiac tissue. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW protects cardiomyocytes treated with LPS, alleviates oxidative stress, repairs mitochondrial function, inhibits ferroptosis and apoptosis, and downregulates the secretion of pro-inflammatory cytokines at the same time. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW improves cardiac injury and pathological morphology in mice with sepsis-induced cardiomyopathy, restores GPX4 expression, and promotes the internalization of cardiomyocyte-derived exosomes, making it suitable for related research on sepsis-induced cardiomyopathy, myocardial ischemia-reperfusion injury, and other conditions .
|
-
- HY-W020780
-
|
mPEG5000-Maleimide
|
Biochemical Assay Reagents
|
Cancer
|
|
mPEG5000-Mal (mPEG5000-Maleimide) is a PEG-derived selective covalent binding agent for sulfhydryl groups (RSGs), which can form irreversible thioether bonds with sulfhydryl groups under near-neutral conditions via the maleimide group. The mechanism of action of mPEG5000-Mal can be divided into two categories: firstly, as an enzyme modifier, it binds to target proteins through hydrophobic interactions, hydrogen bonds, and van der Waals forces, altering the protein's secondary structure; secondly, as a nanoparticle surface modifier, it covalently binds to sulfhydryl groups on the surface of red blood cells, changing the surface properties and morphology of the red blood cells, leading to their phagocytosis by macrophages of the reticuloendothelial system. mPEG5000-Mal can react with free cysteine in proteins, increasing the apparent molecular weight of the modified protein by 10-15 kDa for detection purposes. mPEG5000-Mal can enhance the thermal stability and catalytic activity of enzymes, and improve the macrophage targeting of nanoparticles, enabling targeted drug delivery. mPEG5000-Mal can be applied in enzyme engineering research in the food industry and in oncology, assisting radiotherapy by inhibiting tumor-associated macrophage infiltration and enhancing anti-tumor immune responses .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-W440916
-
|
|
Fluorescent Dyes
|
|
DSPE-PEG3400-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
| Cat. No. |
Product Name |
Type |
-
- HY-144009
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG-Folate, MW 3350 is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440917
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG5000-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
- HY-W441015A
-
|
|
Biochemical Assay Reagents
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
- HY-W440916
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
- HY-W440890
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG-Folate, MW 5000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 5000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 5000 form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440833
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-azide is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelles formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form triazole bond.
|
-
- HY-166975
-
|
pSar 100
|
Biochemical Assay Reagents
|
|
Polysarcosine 100 (pSar 100) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 100 can be used in drug delivery research .
|
-
- HY-W1123932A
-
|
mPEG2000-Folate
|
Biochemical Assay Reagents
|
|
mPEG2000-FA (mPEG2000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-W440899
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG1000-SPDP is a thiol reactive PEG lipid. The polymer is amphiphilic and spontaneously forms lipid bilayer in water. It can be used to encapsulate nutrients or therapeutics for targeted drug delivery, for example mRNA or DNA vaccine, liposomal doxorubicin for anti tumor.
|
-
- HY-174972A
-
|
|
Biochemical Assay Reagents
|
|
mPEG-DPPE (MW 5000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174947
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2-mal is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-W440892
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-OH is an amphiphilic polydisperse PEG which can spontaneously self-assemble in aqueous solution. The polymer can be used to prepare liposoome for targeted drug delivery.
|
-
- HY-166973
-
|
pSar 20
|
Biochemical Assay Reagents
|
|
Polysarcosine 20 (pSar 20) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 20 can be used in drug delivery research .
|
-
- HY-166974
-
|
pSar 150
|
Biochemical Assay Reagents
|
|
Polysarcosine 150 (pSar 150) is a hydrophilic alternative to PEG that has good targeted drug delivery properties and can remain in the bloodstream longer. Polysarcosine 150 can be used in drug delivery research .
|
-
- HY-W1123932
-
|
mPEG1000-Folate
|
Biochemical Assay Reagents
|
|
mPEG1000-FA (mPEG1000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-W440888B
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440888A
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG1000-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440921
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG5000-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
- HY-W440920
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
- HY-W440888C
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG5000-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-174966B
-
|
BOC-NH-PEG1000-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG1000-FA (BOC-NH-PEG1000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174966
-
|
BOC-NH-PEG400-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG400-FA (BOC-NH-PEG400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-W1123945
-
|
8-Arm-PEG400-Folate
|
Biochemical Assay Reagents
|
|
8-Arm-PEG400-FA (8-Arm-PEG400-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
-
- HY-W1130412
-
|
|
Biochemical Assay Reagents
|
|
DLPE-mPEG2000 is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174972
-
|
|
Biochemical Assay Reagents
|
|
mPEG-DPPE (MW 1000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381E
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DSG is a PEGylated phospholipid containing DSG. mPEG1000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381B
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DSG is a PEGylated phospholipid containing DSG. mPEG500-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192B
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DMPE is a PEGylated phospholipid containing DMPE. mPEG20000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381C
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DSG is a PEGylated phospholipid containing DSG. mPEG550-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052192C
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DMPE is a PEGylated phospholipid containing DMPE. mPEG30000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624C
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DSG is a PEGylated phospholipid containing DSG. mPEG20000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W591381H
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DSG is a PEGylated phospholipid containing DSG. mPEG30000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624B
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DSG is a PEGylated phospholipid containing DSG. mPEG10000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1048624A
-
|
|
Biochemical Assay Reagents
|
|
mPEG5000-DSG is a PEGylated phospholipid containing DSG. mPEG5000-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1123932B
-
|
mPEG5000-Folate
|
Biochemical Assay Reagents
|
|
mPEG5000-FA (mPEG5000-Folate) is a polyethylene glycol derivative of Folic acid (HY-16637). Folic acid has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
- HY-W591381D
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DSG is a PEGylated phospholipid containing DSG. mPEG750-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
- HY-W1052192A
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DMPE is a PEGylated phospholipid containing DMPE. mPEG10000-DMPE combines the membrane fusion capability of DMPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
- HY-W591381A
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DSG is a PEGylated phospholipid containing DSG. mPEG350-DSG combines the membrane fusion capability of DSG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
- HY-183170C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG5000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183170
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG1000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183170B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG3400-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183170A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG2000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183170D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG10000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-182981A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-182981
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-182981B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-182981C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-182981D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-174966D
-
|
BOC-NH-PEG3400-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG3400-FA (BOC-NH-PEG3400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-183164B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG3400-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-174966C
-
|
BOC-NH-PEG2000-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG2000-FA (BOC-NH-PEG2000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174966E
-
|
BOC-NH-PEG5000-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG5000-FA (BOC-NH-PEG5000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-183164A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG2000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183164D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG10000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183164
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG1000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-174966H
-
|
BOC-NH-PEG10000-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG10000-FA (BOC-NH-PEG10000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174966A
-
|
BOC-NH-PEG600-Folate
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG600-FA (BOC-NH-PEG600-Folate) is a PEG derivative modified with Folic acid (HY-16637). Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-183164C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG5000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183160B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG3400-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183160A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG2000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183160D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG10000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183160
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG1000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183160C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG5000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG10000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG3400-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG1000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG2000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG5000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-W1123921E
-
|
4-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG5000-FA (4-Arm-PEG5000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921
-
|
4-Arm-PEG400-folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG400-FA (4-Arm-PEG400-folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921A
-
|
4-Arm-PEG600-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG600-FA (4-Arm-PEG600-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123945E
-
|
8-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
|
8-Arm-PEG5000-FA (8-Arm-PEG5000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921C
-
|
4-Arm-PEG2000-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG2000-FA (4-Arm-PEG2000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123945H
-
|
8-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
|
8-Arm-PEG10000-FA (8-Arm-PEG10000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921H
-
|
4-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG10000-FA (4-Arm-PEG10000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921B
-
|
4-Arm-PEG1000-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG1000-FA (4-Arm-PEG1000-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W1123921D
-
|
4-Arm-PEG3400-Folate
|
Biochemical Assay Reagents
|
|
4-Arm-PEG3400-FA (4-Arm-PEG3400-Folate) is a PEG derivative with one Folic acid (HY-16637) molecule attached to each end of the PEG chain. Folic acid has a high affinity for folate receptors and can be used for targeted drug delivery to cell membrane receptors .
|
- HY-W440903
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG5000-IA is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
- HY-W440926
-
|
|
Biochemical Assay Reagents
|
|
Stearic acid-PEG1000-NHS is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
- HY-W591332A
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the?other?end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications .
|
- HY-183162A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG2000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
- HY-183162D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG10000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183162
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG1000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
- HY-183162B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG3400-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
- HY-174892
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG5-NHS ester is a heterobifunctional crosslinker as well as a polyethylene glycol-containing bioconjugation reagent. Biotin-PEG5-NHS ester is widely used in scientific research fields such as the construction of highly sensitive biosensors, the development of targeted drug delivery systems (e.g., liposome modification), immunofluorescence imaging, and protein affinity purification, and serves as an important tool for achieving precise labeling and functionalization of biomolecules .
|
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161
-
|
Glucose-PEG1000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183162C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-NHS is a conjugate composed of glucose, PEG chains, and an active ester (NHS). Glucose-PEG5000-NHS combines the targeted recognition capabilities of glucose with the ability to rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and amino-modified small molecules) to form stable amide bonds in an NHS ester. This allows for applications such as constructing targeted drug delivery systems and modifying nanoparticles.
|
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-174960D
-
|
6-Arm-PEG3400-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG3400-FA (6-Arm-PEG3400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-182095A
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG2000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG2000-CTP can be used for drug delivery .
|
- HY-174960E
-
|
6-Arm-PEG5000-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG5000-FA (6-Arm-PEG5000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174960B
-
|
6-Arm-PEG1000-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG1000-FA (6-Arm-PEG1000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174960A
-
|
6-Arm-PEG600-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG600-FA (6-Arm-PEG600-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174960C
-
|
6-Arm-PEG2000-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG2000-FA (6-Arm-PEG2000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-182095B
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG3400-CTP can be used for drug delivery .
|
- HY-182095C
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG5000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG5000-CTP can be used for drug delivery .
|
- HY-174960
-
|
6-Arm-PEG400-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG400-FA (6-Arm-PEG400-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-174960H
-
|
6-Arm-PEG10000-Folate
|
Biochemical Assay Reagents
|
|
6-Arm-PEG10000-FA (6-Arm-PEG10000-Folate) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .
|
- HY-182095
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG1000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG1000-CTP can be used for drug delivery .
|
- HY-W440888
-
|
DSPE-PEG2000(2000) Folate
|
Biochemical Assay Reagents
|
|
DSPE-PEG2000-Folate (DSPE-PEG2000 Folate) is a folate-containing PEG derivative. DSPE-PEG2000-Folate possesses targeting activity and binds to folate receptors in cancer cells. DSPE-PEG2000-Folate can be post-inserted into preformed liposomal bilayers to prepare folate-targeted liposomal formulations. DSPE-PEG2000-Folate forms micelles/lipid bilayers and can be used in studies of targeted drug delivery systems [2].
|
- HY-172705
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG2000-RVG29 is a PEG conjugate composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB), crosses the BBB, and mediates receptor-dependent transcytosis. DSPE-PEG2000-RVG29 can be used for brain-targeted drug delivery, surface modification of nanocarriers, as well as gene and nucleic acid delivery. DSPE-PEG2000-RVG29 is applicable to research related to hypoxic-ischemic brain injury, Parkinson's disease, and other conditions .
|
- HY-172705A
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG3400-RVG29 is a PEG conjugate composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB), crosses the BBB, and mediates receptor-dependent transcytosis. DSPE-PEG3400-RVG29 can be used for brain-targeted drug delivery, surface modification of nanocarriers, as well as gene and nucleic acid delivery. DSPE-PEG3400-RVG29 is applicable to research related to hypoxic-ischemic brain injury, Parkinson's disease, and other conditions
|
- HY-177204
-
|
|
Biochemical Assay Reagents
|
|
DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW is a polypeptide targeting tenascin-X (Tenascin-X) that can be conjugated with liposomes and exosomes. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW specifically binds to Tenascin-X on the surface of cardiomyocytes, mediates receptor-dependent uptake of nanocarriers, enhances targeted drug delivery of cargo to cardiomyocytes, and increases drug accumulation in cardiac tissue. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW protects cardiomyocytes treated with LPS, alleviates oxidative stress, repairs mitochondrial function, inhibits ferroptosis and apoptosis, and downregulates the secretion of pro-inflammatory cytokines at the same time. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW improves cardiac injury and pathological morphology in mice with sepsis-induced cardiomyopathy, restores GPX4 expression, and promotes the internalization of cardiomyocyte-derived exosomes, making it suitable for related research on sepsis-induced cardiomyopathy, myocardial ischemia-reperfusion injury, and other conditions .
|
- HY-W020780
-
|
mPEG5000-Maleimide
|
Biochemical Assay Reagents
|
|
mPEG5000-Mal (mPEG5000-Maleimide) is a PEG-derived selective covalent binding agent for sulfhydryl groups (RSGs), which can form irreversible thioether bonds with sulfhydryl groups under near-neutral conditions via the maleimide group. The mechanism of action of mPEG5000-Mal can be divided into two categories: firstly, as an enzyme modifier, it binds to target proteins through hydrophobic interactions, hydrogen bonds, and van der Waals forces, altering the protein's secondary structure; secondly, as a nanoparticle surface modifier, it covalently binds to sulfhydryl groups on the surface of red blood cells, changing the surface properties and morphology of the red blood cells, leading to their phagocytosis by macrophages of the reticuloendothelial system. mPEG5000-Mal can react with free cysteine in proteins, increasing the apparent molecular weight of the modified protein by 10-15 kDa for detection purposes. mPEG5000-Mal can enhance the thermal stability and catalytic activity of enzymes, and improve the macrophage targeting of nanoparticles, enabling targeted drug delivery. mPEG5000-Mal can be applied in enzyme engineering research in the food industry and in oncology, assisting radiotherapy by inhibiting tumor-associated macrophage infiltration and enhancing anti-tumor immune responses .
|
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P5423
-
|
|
Exosomes
Liposome
|
Cancer
|
|
GALA is a pH-responsive amphipathic peptide consisting of 30 amino acids, which acts as a lung endothelium-targeting ligand. GALA undergoes a conformational transition from random coil to α-helix in an acidic environment at pH 5.0, thereby inducing endosomal membrane destabilization and fusion. GALA-modified liposomes traverse lung endothelial cells via clathrin-dependent endocytosis and transcytosis, and specifically accumulate in the lungs after intravenous injection. GALA significantly promotes the cytosolic release of cargos carried by exosomes, plasmids and liposomes, effectively enhances gene transfection efficiency, and drives gene knockdown of functional macromolecules (such as siRNA) in alveolar epithelial cells (with no significant cytotoxicity at effective concentrations). GALA serves as a critical tool for studies on lung cancer metastasis (e.g., melanoma lung metastasis) and lung-targeted drug delivery systems .
|
-
- HY-P1848
-
|
|
Interleukin Related
|
Cancer
|
|
Pep-1 (uncapped) is a specific ligand of IL-13Ra2. Pep-1 (uncapped) exerts cell penetrating activity through receptor-mediated endocytosis, can cross the blood-tumor barrier (BTB) and target glioma cells. Pep-1 (uncapped) can enhance the uptake of nanoparticles by tumor cells and enhance the cell penetration ability of nanoparticles, and can be used to develop targeted drug delivery systems for glioma .
|
-
- HY-P2548
-
|
|
EGFR
|
Others
|
|
pp60 (v-SRC) Autophosphorylation Site, Phosphorylated is the phosphorylated peptide of an EGFR substrate. pp60 (v-SRC) Autophosphorylation Site, Phosphorylated can be used for the screening of EGFR Kinase inhibitors via phosphorylated-substrate quantification .
|
-
- HY-P10789
-
|
|
Microtubule/Tubulin
|
Cancer
|
|
The P160 peptide is a breast cancer-targeting peptide that binds to the keratin 1 (KRT1) receptor on breast cancer cells, with a Kd of approximately 1.1 μM, demonstrating significant potential for targeted drug delivery to breast cancer cells. The P160 peptide enhances the cellular uptake and anticancer activity of the pro-apoptotic antimicrobial peptide MccJ25 (microcin J25). The P160 peptide can be used in cancer research .
|
-
- HY-P11015
-
|
|
Ephrin Receptor
|
Cancer
|
|
(123B9)2-Motif is a selective EphA2 receptor agonist (Kd=4.9 μM) that does not bind to EphA4. (123B9)2-Motif works by inducing EphA2 receptor phosphorylation and oligomerization, thereby promoting receptor activation and internalization. (123B9)2-Motif is primarily used in targeted drug delivery studies for cancers that overexpress EphA2, such as breast cancer, to reduce circulating tumor cells and inhibit metastasis .
|
-
- HY-P10983
-
|
|
Biochemical Assay Reagents
|
Cancer
|
|
LS10 can specifically bind to NG2 protein and is a functional ligand for targeted drug delivery to glioma. NG2 proteins are widely overexpressed in the glioma cells and restricted in normal tissue .
|
-
- HY-P4096A
-
|
|
Peptides
|
Inflammation/Immunology
|
|
Cys-HAP-1 is a synovium-homing peptide that specifically binds to human and rabbit fibroblast-like synoviocytes, and does not bind to human umbilical vein endothelial cells regardless of TNF-α treatment. Cys-HAP-1 enables targeted drug delivery to inflamed joints after conjugation with liposomes loaded with anti-arthritic agents. Cys-HAP-1 can be used in studies related to adjuvant arthritis .
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-160523
-
|
|
|
DBCO
|
|
DBCO Ir catalyst is an iridium catalyst labeled with DBCO. DBCO Ir catalyst can be used for in situ labeling and imaging of biomolecules (e.g., proteins, nucleic acids) in living organisms or for constructing targeted drug delivery systems .
|
-
- HY-W440833
-
|
|
|
Azide
|
|
DSPE-PEG3400-azide is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelles formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form triazole bond.
|
-
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
|
Azide
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
|
Azide
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161
-
|
Glucose-PEG1000-Azide
|
|
Azide
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
|
Azide
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
|
Azide
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-144009
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG-Folate, MW 3350 is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440888
-
|
DSPE-PEG2000(2000) Folate
|
|
Pegylated Lipids
|
|
DSPE-PEG2000-Folate (DSPE-PEG2000 Folate) is a folate-containing PEG derivative. DSPE-PEG2000-Folate possesses targeting activity and binds to folate receptors in cancer cells. DSPE-PEG2000-Folate can be post-inserted into preformed liposomal bilayers to prepare folate-targeted liposomal formulations. DSPE-PEG2000-Folate forms micelles/lipid bilayers and can be used in studies of targeted drug delivery systems [2].
|
-
- HY-N5139
-
|
Lecithins, egg yolk; Belovo PL 85
|
|
Emulsifiers
Liposomal Film-forming Agents
Solubilizing Agents
|
|
Lecithins, egg (Lecithins, egg yolk; Belovo PL 85) is an orally active natural phospholipid mixture extracted from egg yolks . Lecithins, egg inhibits the activities of acetylcholinesterase (AChE) and angiotensin-converting enzyme (ACE). Lecithins, egg exhibits antibacterial, antioxidant and anti-inflammatory activities, and helps delay cellular senescence. Lecithins, egg enhances nerve conduction, improves memory and cognitive function, and exerts positive effects on delaying neurodegenerative diseases. Lecithins, egg promotes lipid absorption and alleviates diarrhea. Lecithins, egg acts as a high-efficiency drug carrier for the preparation of targeted drug delivery systems such as liposomes .
|
-
- HY-W440917
-
|
|
|
Pegylated Lipids
Fluorescent Lipids
|
|
DSPE-PEG5000-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
- HY-177204
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW is a polypeptide targeting tenascin-X (Tenascin-X) that can be conjugated with liposomes and exosomes. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW specifically binds to Tenascin-X on the surface of cardiomyocytes, mediates receptor-dependent uptake of nanocarriers, enhances targeted drug delivery of cargo to cardiomyocytes, and increases drug accumulation in cardiac tissue. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW protects cardiomyocytes treated with LPS, alleviates oxidative stress, repairs mitochondrial function, inhibits ferroptosis and apoptosis, and downregulates the secretion of pro-inflammatory cytokines at the same time. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW improves cardiac injury and pathological morphology in mice with sepsis-induced cardiomyopathy, restores GPX4 expression, and promotes the internalization of cardiomyocyte-derived exosomes, making it suitable for related research on sepsis-induced cardiomyopathy, myocardial ischemia-reperfusion injury, and other conditions .
|
-
- HY-139819
-
|
|
|
Polymers
|
|
MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer, which can be used to preparenanoparticles for targeted drug delivery .
|
-
- HY-W441015A
-
|
|
|
Pegylated Lipids
|
|
DSPE-m-PEG3400-NHS is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
|
-
- HY-W440916
-
|
|
|
Pegylated Lipids
Fluorescent Lipids
|
|
DSPE-PEG3400-FITC is a fluorescein attached PEG lipid. It can be used to prepare liposomes as drug carrier in targeted drug delivery. The polymer is modified with fluorescein (green) dye which can be used for staining cells, tissues, biomarkers, or nanoparticles.
|
-
- HY-W440890
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG-Folate, MW 5000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 5000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 5000 form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-172705
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG2000-RVG29 is a PEG conjugate composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB), crosses the BBB, and mediates receptor-dependent transcytosis. DSPE-PEG2000-RVG29 can be used for brain-targeted drug delivery, surface modification of nanocarriers, as well as gene and nucleic acid delivery. DSPE-PEG2000-RVG29 is applicable to research related to hypoxic-ischemic brain injury, Parkinson's disease, and other conditions .
|
-
- HY-W440833
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG3400-azide is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelles formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form triazole bond.
|
-
- HY-139818
-
|
|
|
Polymers
|
|
Mal-PEG-PLA (PEG MW 3000 & PLA MW 70,000) is a block copolymer, which can be used to preparenanoparticles and micelles for targeted drug delivery .
|
-
- HY-W440899
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG1000-SPDP is a thiol reactive PEG lipid. The polymer is amphiphilic and spontaneously forms lipid bilayer in water. It can be used to encapsulate nutrients or therapeutics for targeted drug delivery, for example mRNA or DNA vaccine, liposomal doxorubicin for anti tumor.
|
-
- HY-W591332
-
|
|
|
Pegylated Lipids
|
|
mPEG2000-DMPE is a PEGylated 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine (14:0 PE) compound with a methyl group at the other end of the PEG chain. The PEG polymer exhibits amphiphatic behavior and helps to form stable micelles in an aqueous solution. It can be used to prepare nanoparticles or liposomes for targeted drug delivery applications.
|
-
- HY-W440926
-
|
|
|
Pegylated Lipids
|
|
Stearic acid-PEG1000-NHS is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
-
- HY-W440892
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG3400-OH is an amphiphilic polydisperse PEG which can spontaneously self-assemble in aqueous solution. The polymer can be used to prepare liposoome for targeted drug delivery.
|
-
- HY-W440921
-
|
|
|
Pegylated Lipids
Fluorescent Lipids
|
|
DSPE-PEG5000-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
- HY-W440920
-
|
|
|
Pegylated Lipids
Fluorescent Lipids
|
|
DSPE-PEG3400-Rhodamine is a phospholipid polyPEG with red fluorescent. The polymer can form lipid bilayer and be used to prepare nanoparticles or liposomes for targeted drug delivery. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
|
-
- HY-W440888C
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG5000-Folate is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
|
-
- HY-W440991
-
|
DOPE-PEG2000-NH2
|
|
Pegylated Lipids
|
|
DOPE-PEG-Amine (MW 2000) is a polydisperse PEG covalently attached to a phospholipid. The polymer is an amphiphilic molecule with hydrophobic fatty acid chains and hydrophilic PEG head which enables lipid bilayer or micelle formation in water. The phospholipid PEG can be used to prepare liposome or nanoparticles for targeted drug delivery and is reactive with alkyne to form a triazole ring.
|
-
- HY-W440903
-
|
|
|
Pegylated Lipids
|
|
DSPE-PEG5000-IA is a cyclooctyne containing phospholipid PEG polymer. The polymer can self-assemble spontaneously in water to form micelles/lipid bilayer. It can be used to prepare nanoparticles or liposomes as drug carrier in targeted drug delivery system. The DBCO can react with azide molecule via copper free click chemistry to form a stable triazole bond.
|
-
- HY-W1130412
-
|
|
|
Pegylated Lipids
|
|
DLPE-mPEG2000 is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: